首页> 外文OA文献 >B1-07: Decreased neurocognitive progression with Motexafin Gadolinium (MGd) plus Whole Brain Radiation Therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with brain metastases: pooled analysis of two randomized phase 3 trials

【2h】

B1-07: Decreased neurocognitive progression with Motexafin Gadolinium (MGd) plus Whole Brain Radiation Therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with brain metastases: pooled analysis of two randomized phase 3 trials

机译：B1-07：Motexafin d（MGd）联合全脑放射治疗（WBRT）在患有脑转移的非小细胞肺癌（NSCLC）患者中的神经认知进展降低：两项3期随机试验的合并分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mehta Minesh; Leibenhaut Mark; Suh John; Meyers Christine; Renschler Markus F.; Smith Jennifer; Phan See C.;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial. [J] . Meyers CA, Bezjak A, Liebmann J, Journal of Clinical Oncology . 2004,第1期

机译：全脑放射和Motexafin d治疗的脑转移患者的神经认知功能和进展：一项随机III期试验的结果。
2. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. [J] . Mehta MP, Shapiro WR, Phan SC, International Journal of Radiation Oncology, Biology, Physics . 2009,第4期

机译：Motexafin with联合迅速的全脑放疗可延长患有脑转移的非小细胞肺癌患者神经发育的时间：一项III期试验的结果。
3. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation therapy oncology group 0320 [J] . SperdutoP.W., WangM., RobinsH.I., International Journal of Radiation Oncology, Biology, Physics . 2013,第5期

机译：单独进行全脑放射治疗和立体定向放射外科手术与WBRT和SRS联合替莫唑胺或厄洛替尼治疗非小细胞肺癌和1至3例脑转移的3期试验：放射治疗肿瘤学组0320
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320 [O] . H. Ian Robins, Anne O’Neill, Minesh Mehta, -1

机译：单独进行全脑放射治疗和立体定向放射外科与WBRT和SRS联合替莫唑胺或厄洛替尼治疗非小细胞肺癌和1至3例脑转移的3期试验：放射治疗肿瘤学小组0320
7. Neurocognitive Function and Quality of Life in EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases Treated With Icotinib and Whole-Brain Radiation: Results of a Phase 1 Trial [O] . B. Chen, L. Zhou, J. He, 2016

机译：EGFR-突变的非小细胞肺癌患者的神经认知功能和生活质量，患有icotinib和全脑辐射治疗的脑转移：1阶段试验的结果

B1-07: Decreased neurocognitive progression with Motexafin Gadolinium (MGd) plus Whole Brain Radiation Therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with brain metastases: pooled analysis of two randomized phase 3 trials

著录项

引文网络

相似文献

相关主题

期刊订阅